Hepatitis C Virus Resistance to Antiviral Therapy
- 1 November 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 32 (5), 889-896
- https://doi.org/10.1053/jhep.2000.19150
Abstract
No abstract availableThis publication has 126 references indexed in Scilit:
- Alpha 2A interferon monotherapy in patients with chronic hepatitis C and repeatedly normal aminotransferase levelsJournal of Hepatology, 2000
- Should the patients with histologically mild chronic hepatitis C betreated?Journal of Hepatology, 2000
- HCV NS5A (1b) mutants show different phosphorylations pattern, inhibitinterferon (IFN) antiviral activity, but do not affect PKR and cellproliferation statusJournal of Hepatology, 2000
- Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2A (PEGASYS™) for chronic hepatitis C. A multinational, randomized studyJournal of Hepatology, 2000
- Pegylated interferon alfa-2B (PEG-intron) mono-therapy is superior to interferon alfa-2B (intron A) for the treatment of chronic hepatitis CJournal of Hepatology, 2000
- Long-term response to interferon alpha is unrelated to“interferon sensitivity determining region” variability in patients with chronic hepatitis C virus-1b infectionJournal of Hepatology, 1999
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Hepatitis C and alcoholJournal of Hepatology, 1999
- The “interferon sensitivity determining region” of hepatitis C virus is a stable sequence elementJournal of Hepatology, 1998
- Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferonJournal of Hepatology, 1997